MedPath

Endocrine and exocrine dysfunction in patients after developing acute pancreatitis

Not Applicable
Conditions
Health Condition 1: K859- Acute pancreatitis, unspecified
Registration Number
CTRI/2020/09/027962
Lead Sponsor
Jayanta Samanta
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients who gave informed consent for participation in the study

2.Patients with age >= 16 years

3. Patients who had a past history of acute pancreatitis

Exclusion Criteria

1.A patient who has suffered recurrent episodes of AP.

2.Patients with chronic pancreatitis.

3.Patient with diagnosed diabetes mellitus before acute pancreatitis episode

4.Patients suffering from chronic diarrhea before AP

5.Patient with intestinal tuberculosis or Crohnâ??s disease

6.Patients who died during hospitalization

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the incidence of endocrine and exocrine pancreatic insufficiency after acute pancreatitis.Timepoint: At 1 month, 3 months after the episode of acute pancreatitis
Secondary Outcome Measures
NameTimeMethod
1.To assess the risk factors of exocrine and endocrine pancreatic insufficiency after first attack of acute pancreatitis. <br/ ><br>2.To assess the effect of necrosectomy (using percutaneous drainage or surgical) on the development of exocrine and endocrine pancreatic insufficiency <br/ ><br>3.To assess the short term (at 6 months) persistent of exocrine and endocrine pancreatic insufficiency after discharge. <br/ ><br>Timepoint: At 1 month, 3 months and 6 months after the episode of acute pancreatitis
© Copyright 2025. All Rights Reserved by MedPath